Immune activation in mismatch repair–deficient carcinogenesis: More than just mutational rate

JA Willis, L Reyes-Uribe, K Chang, SM Lipkin… - Clinical Cancer …, 2020 - AACR
Mismatch repair (MMR)–deficient colorectal cancers (dMMR colorectal cancer) are
characterized by the expression of highly immunogenic neoantigen peptides, which …

Exercise and colon cancer: primary and secondary prevention

TH Trojian, K Mody, P Chain - Current Sports Medicine Reports, 2007 - Springer
Many studies have demonstrated the effects of exercise on both primary and secondary
prevention of colon cancer. Exercise appears to have a dose-response reduction in the rate …

[HTML][HTML] Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers

YF Han, GW Cao - World journal of gastroenterology: WJG, 2012 - ncbi.nlm.nih.gov
NR4A2 is a transcription factor belonging to the steroid orphan nuclear receptor superfamily.
It was originally considered to be essential in the generation and maintenance of …

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study

MV Grau, RS Sandler… - JNCI: Journal of the …, 2009 - academic.oup.com
Background Frequent use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been
shown to reduce the risk of colorectal adenomas in randomized trials. We examined the …

[HTML][HTML] Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative …

Y Han, H Cai, L Ma, Y Ding, X Tan, Y Liu, T Su… - European journal of …, 2013 - Elsevier
Background NR4A2, an orphan nuclear receptor essential in neuron generation, has been
recently linked to inflammatory and metabolic pathways of colorectal carcinoma (CRC) …

The use of Cox-2 and PPARγ signaling in anti-cancer therapies

L Knopfová, J Šmarda - Experimental and therapeutic …, 2010 - spandidos-publications.com
Increased production of the pro-inflammatory enzyme cyclooxygenase-2 (Cox-2) and altered
expression and activity of peroxisome proliferator-activated receptor γ (PPARγ) have been …

Genetic variation in inflammatory pathways is related to colorectal cancer survival

AE Coghill, PA Newcomb, EM Poole, CM Hutter… - Clinical Cancer …, 2011 - AACR
Purpose: Prognosis of patients with colorectal cancer (CRC) is associated with systemic
inflammation, and anti-inflammatory drugs can reduce both CRC incidence and mortality …

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women

AE Coghill, PA Newcomb, VM Chia, Y Zheng… - British journal of …, 2011 - nature.com
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and hormone therapy (HT)
independently decrease the risk of colorectal cancer. However, their role in altering survival …

Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation

A Garufi, G Pistritto, C Ceci, L Di Renzo, R Santarelli… - PloS one, 2012 - journals.plos.org
Background Homeodomain-interacting protein kinase 2 (HIPK2) is a multifunctional protein
that exploits its kinase activity to modulate key molecular pathways in cancer to restrain …

Molecular basis for maize as a risk factor for esophageal cancer in a South African population via a prostaglandin E2 positive feedback mechanism

RC Pink, TA Bailey, JE Iputo, AM Sammon… - Nutrition and …, 2011 - Taylor & Francis
The incidence of squamous cancer of the esophagus varies up to a hundredfold in different
regions of the world. In Transkei, South Africa, a particularly high incidence of the disease is …